This difference may be because the majority of research on ECM/HIF-1 has been focused on cancer cell lines [MCF-7 (human mammary tumor), U251 (human glioma), and HepG2 (hepatocellular carcinoma) cells] (47), which may behave differently than non-cancerous cardiomyocytes. Here, HIF1A is linked to central nervous system cancer.